Arcutis Biotherapeutics (NASDAQ:ARQT) reported fourth-quarter and full-year fiscal 2025 results highlighted by sharp growth in ZORYVE net product revenue, additional FDA approvals, and an outlook that management said reflects continued momentum alongside stepped-up investment in commercialization and pipeline programs. 2025 growth and updated 2026 outlook President and CEO Frank Watanabe said 2025 was marked by [...]
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) issued its quarterly earnings results on Wednesday. The technology company reported $0.28 earnings per share (EPS) for the quarter, Zacks reports. Kewaunee Scientific had a net margin of 4.11% and a return on equity of 22.39%. The business had revenue
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) announced its quarterly earnings data on Wednesday. The technology company reported $0.28 EPS for the quarter, Zacks reports. Kewaunee Scientific had a net margin of 4.11% and a return on equity of 22.39%. The company had revenue of $69.40
Xunlei (NASDAQ:XNET – Get Free Report) released its quarterly earnings results on Thursday. The software maker reported $0.02 EPS for the quarter, FiscalAI reports. Xunlei had a return on equity of 2.75% and a net margin of 315.06%.The firm had revenue of $142.50 million for
The Progressive Corporation (NYSE:PGR – Get Free Report) CAO Carl Joyce sold 141 shares of the business’s stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of $212.00, for a total value of $29,892.00. Following the completion of the
